ID: ALA535214

Max Phase: Preclinical

Molecular Formula: C14H14N4O

Molecular Weight: 254.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)Nc1ccc(C(=O)Nc2ccccc2)cc1

Standard InChI:  InChI=1S/C14H14N4O/c15-14(16)18-12-8-6-10(7-9-12)13(19)17-11-4-2-1-3-5-11/h1-9H,(H,17,19)(H4,15,16,18)

Standard InChI Key:  GRJDAVAWSPBJTJ-UHFFFAOYSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.29Molecular Weight (Monoisotopic): 254.1168AlogP: 2.24#Rotatable Bonds: 3
Polar Surface Area: 91.00Molecular Species: BASEHBA: 2HBD: 4
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.64CX LogP: 2.04CX LogD: 0.80
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.50Np Likeness Score: -0.93

References

1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW..  (2015)  Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.,  23  (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072]

Source